Principal Global Investors Discloses 2.8% Stake in Brookfield
Principal Global Investors, LLC reveals a 2.8% ownership stake in Brookfield Infrastructure Partners, indicating strong interest in the water transportation sector.
Principal Life and Global Investors Hold 160,000 Shares in Ares
Principal Life Insurance Co and Principal Global Investors jointly hold 160,000 shares in Ares Dynamic Credit Allocation Fund, Inc., per recent SEC filing.
Rising Dragon Acquisition Corp. Issues Promissory Notes to Extend Merger
Rising Dragon Acquisition Corp. issues $55,637.41 in promissory notes to extend merger timeline as it works towards a business combination.
Lucky Mark Burdon Becomes Sole Director of Visium Technologies
Lucky Mark Burdon's recent filing shows he is now the sole director of Visium Technologies, following the CEO's resignation. Key ownership changes are noted.
Principal Global Investors increases stake in Hyatt Hotels Corp
Principal Global Investors has increased its stake in Hyatt Hotels Corp to 9.4%, signaling strong investment interest in the hotel and motel sector.
APEX Tech Acquisition Inc. files amended Schedule 13G
APEX Tech Acquisition Inc. files an amended Schedule 13G with no changes in UBS Group AG's ownership, indicating stability in the blank check company sector.
Sprang Todd A. acquires additional shares in Bank First Corp
Sprang Todd A. increases his stake in Bank First Corp by acquiring 400 shares, now holding a total of 2,431 shares.
Hopmayer acquires 455,203 shares in MDWerks, Inc.
Jeffrey Scott Hopmayer increases his stake in MDWerks, Inc. by acquiring 455,203 shares, reflecting confidence in the company's future.
Brocopp Timothy acquires 148,401 shares of MDWerks, Inc.
Timothy Brocopp reports acquisition of 148,401 shares of MDWerks, Inc., increasing his total ownership to over 3.4 million shares.
ADT Inc. to be Acquired by Thrive Holdings in $15.3 Billion Deal
ADT Inc. announces acquisition by Thrive Holdings for $15.3 billion, enhancing service capabilities and technology investments.
Celularity, Vesalius Partner on U.S. Peptide Manufacturing
Celularity Inc. partners with Vesalius Longevity Labs for U.S.-based peptide active pharmaceutical ingredient manufacturing, enhancing domestic production.
Inflection Point Acquisition Corp. VI's Merger with Quantum Space Approved
Inflection Point Acquisition Corp. VI's merger with Quantum Space, LLC has received SEC approval, marking a key step in the blank check company's business combination.
Inflection Point Acquisition Corp. VI secures SEC approval for merger
Inflection Point Acquisition Corp. VI receives SEC approval for its merger with Quantum Space, marking a significant milestone in the SPAC industry.
Varex Imaging secures stockholder approval for Teledyne merger
Varex Imaging Corp has received stockholder approval for its merger with Teledyne Technologies, a significant move in the electronic components industry.
Murchinson Ltd. Updates Stake in Nano Dimension Ltd.
Murchinson Ltd. amends its Schedule 13D, revealing a 10.1% stake in Nano Dimension Ltd. and detailing recent transactions involving American Depositary Shares.
Perrigo to Sell Infant Formula Business to MeridianMade
Perrigo Co plc has entered an agreement to divest its Infant Formula business to MeridianMade for up to $175 million, aiming to streamline operations and enhance margins.
DoorDash announces merger with Instacart in major deal
DoorDash, Inc. has entered into a merger agreement with Instacart, marking a significant move in the business services sector.
IperionX reports Q3 2026 results, highlights production growth
IperionX Ltd's Q3 2026 report reveals advancements in titanium powder production and operational capacity, enhancing its competitive edge.
OMNIQ Corp. Wins Contract for Uninsured Vehicle Enforcement
OMNIQ Corp. announces a two-year contract to deploy its Q Shield platform in Arkansas, expanding its market presence in uninsured vehicle enforcement.
Processa Pharmaceuticals appoints Dr. Sheila Gujrathi as Executive Chair
Processa Pharmaceuticals announces Dr. Sheila Gujrathi as new Executive Chair, succeeding Justin Yorke, amid ongoing clinical advancements.